1. Home
  2. CCEC vs COLL Comparison

CCEC vs COLL Comparison

Compare CCEC & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CCEC
  • COLL
  • Stock Information
  • Founded
  • CCEC 2007
  • COLL 2002
  • Country
  • CCEC Greece
  • COLL United States
  • Employees
  • CCEC N/A
  • COLL N/A
  • Industry
  • CCEC Marine Transportation
  • COLL Biotechnology: Pharmaceutical Preparations
  • Sector
  • CCEC Consumer Discretionary
  • COLL Health Care
  • Exchange
  • CCEC Nasdaq
  • COLL Nasdaq
  • Market Cap
  • CCEC 1.4B
  • COLL 958.8M
  • IPO Year
  • CCEC 2007
  • COLL 2015
  • Fundamental
  • Price
  • CCEC $23.65
  • COLL $30.35
  • Analyst Decision
  • CCEC Buy
  • COLL Strong Buy
  • Analyst Count
  • CCEC 2
  • COLL 4
  • Target Price
  • CCEC $24.00
  • COLL $43.75
  • AVG Volume (30 Days)
  • CCEC 8.1K
  • COLL 289.9K
  • Earning Date
  • CCEC 08-01-2025
  • COLL 08-07-2025
  • Dividend Yield
  • CCEC 2.54%
  • COLL N/A
  • EPS Growth
  • CCEC 44.72
  • COLL N/A
  • EPS
  • CCEC 3.36
  • COLL 1.25
  • Revenue
  • CCEC $402,628,000.00
  • COLL $664,283,000.00
  • Revenue This Year
  • CCEC $19.03
  • COLL $20.04
  • Revenue Next Year
  • CCEC $13.94
  • COLL $3.98
  • P/E Ratio
  • CCEC $40.82
  • COLL $24.19
  • Revenue Growth
  • CCEC 69.94
  • COLL 17.17
  • 52 Week Low
  • CCEC $14.09
  • COLL $23.23
  • 52 Week High
  • CCEC $24.33
  • COLL $42.29
  • Technical
  • Relative Strength Index (RSI)
  • CCEC N/A
  • COLL 54.25
  • Support Level
  • CCEC N/A
  • COLL $29.28
  • Resistance Level
  • CCEC N/A
  • COLL $30.83
  • Average True Range (ATR)
  • CCEC 0.00
  • COLL 0.75
  • MACD
  • CCEC 0.00
  • COLL -0.00
  • Stochastic Oscillator
  • CCEC 0.00
  • COLL 51.63

About CCEC Capital Clean Energy Carriers Corp. Common Share

Capital Clean Energy Carriers Corp is an international shipping company. It is the platform of gas carriage solutions with a focus on the energy transition. The company owns 20 high-specification vessels, including 12 latest-generation LNG carriers (LNG/Cs) and eight legacy Neo-Panamax container vessels.

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.

Share on Social Networks: